Supplementary Data 1 from Pilot Study of ONCOS-102 and Pembrolizumab: Remodeling of the Tumor Microenvironment and Clinical Outcomes in Anti–PD-1–Resistant Advanced Melanoma

<p>Immunologic pathway genes</p>

Enregistré dans:

Détails bibliographiques
Auteur principal:	Alexander N. Shoushtari (15023909) (author)
Autres auteurs:	Anthony J. Olszanski (15031292) (author), Marta Nyakas (15051200) (author), Thomas J. Hornyak (15051203) (author), Jedd D. Wolchok (15032924) (author), Victor Levitsky (15051206) (author), Lukasz Kuryk (15051209) (author), Thomas B. Hansen (15051212) (author), Magnus Jäderberg (15051215) (author)
Publié:	2025
Sujets:	Cancer Tumor Biology Clinical Research and Trials Clinical-Stage Research Skin Cancers Melanoma Tumor Microenvironment Immune cells and the microenvironment
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires